Last reviewed · How we verify
Placebo to match budesonide/formoterol — Competitive Intelligence Brief
marketed
Respiratory
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo to match budesonide/formoterol (Placebo to match budesonide/formoterol) — GlaxoSmithKline. This is an inert placebo formulation designed to match the physical and sensory characteristics of budesonide/formoterol inhaler for blinded clinical trial purposes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo to match budesonide/formoterol TARGET | Placebo to match budesonide/formoterol | GlaxoSmithKline | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo to match budesonide/formoterol CI watch — RSS
- Placebo to match budesonide/formoterol CI watch — Atom
- Placebo to match budesonide/formoterol CI watch — JSON
- Placebo to match budesonide/formoterol alone — RSS
Cite this brief
Drug Landscape (2026). Placebo to match budesonide/formoterol — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-match-budesonide-formoterol. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab